Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1983-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM-57-4-700PMID 6224805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T LYMPHOCYTE SENSITIZATION AND SUPPRESSOR T LYMPHOCYTE DEFECT IN PATIENTS LONG AFTER TREATMENT FOR GRAVES’DISEASE

  1983cited by this paper
• Autoimmunity in the endocrine system by Robert Volpé, Springer-Verlag, 1981, $44.70 (x+187pages)ISBN 3 540 90677 4.

  1983cited by this paper
• Deficiency of suppressor T-cells in insulin-dependent diabetes mellitus: an analysis with monoclonal antibodies.

  1982cited by this paper
• In vitro detection of anti-thyroglobulin antibody forming cells from the lymphocytes of chronic thyroiditis patients and analysis of their regulation.

  1982cited by this paper
• ALLOSUPPRESSOR T LYMPHOCYTES ABOLISH MIGRATION INHIBITION FACTOR PRODUCTION IN AUTOIMMUNE THYROID DISEASE: EVIDENCE FROM RADIOSENSITIVITY EXPERIMENTS

  1981cited by this paper
• Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytes.

  1981cited by this paper
• Autoimmunity in insulin-dependent diabetes mellitus.

  1981cited by this paper
• Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease.

  1981cited by this paper
• Defective suppressor cell generation in juvenile onset diabetes.

  1981cited by this paper
• T-lymphocyte sensitization in Graves' and Hashimoto's diseases confirmed by an indirect migration inhibition factor test.

  1981cited by this paper
• Suppressor T-lymphocyte deficiency in Graves' disease and Hashimoto's thyroiditis.

  1981cited by this paper
• Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus.

  1980cited by this paper
• Sensitization of T-lymphocytes in Graves' and Hashimoto's diseases.

  1980cited by this paper
• Negative allogeneic effects in vitro. I. Allogeneic T cells markedly suppress the secondary antibody-forming cell response.

  1977cited by this paper
• Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

  1977cited by this paper
• Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.

  1977cited by this paper
• Leukocyte migration inhibitory factor (LIF) as an indicator of mixed lymphocyte culture (MLC) reactivity.

  1977cited by this paper
• Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes.

  1976cited by this paper
• Islet-cell antibodies in diabetes mellitus.

  1976cited by this paper
• Cell-mediated Immunity to Human Pancreas in Diabetes Mellitus

  1974cited by this paper
• Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

  1974cited by this paper
• Cell-mediated immunity in diabetes mellitus.

  1974cited by this paper
• ANTI‐PANCREATIC, CELLULAR HYPERSENSITIVITY IN DIABETES MELLITUS. ANTIGENIC ACTIVITY OF FETAL CALF PANCREAS AND CORRELATION WITH CLINICAL TYPE OF DIABETES

  1973cited by this paper
• Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).

  1973cited by this paper
• Antipancreatic Cellular Hypersensitivity in Diabetes Mellitus

  1971cited by this paper
• Reaction of Human Lymphocytes in Culture to Components of the Medium

  1965cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Risk factors of cytomegalovirus reactivation in patients with rheumatic musculoskeletal diseases undergoing remission induction therapy with high-dose glucocorticoids; a prospective short-term cohort study

  2025cites this paper
• Demographic and clinical characteristics of cytomegalovirus reactivation in dermatomyositis.

  2020cites this paper
• Autoimmune polyglandular diseases.

  2019cites this paper
• Celiac disease and endocrine autoimmunity - the genetic link.

  2018cites this paper
• Aggravation of type 2 diabetes mellitus triggered by acute exacerbation of chronic thyroiditis (Hashimoto's disease)

  2018cites this paper
• Polyglandular autoimmune syndromes

  2017cites this paper
• Specific immunotherapy in insulin-dependent diabetes mellitus (preliminary report).

  2009cites this paper
• Defect of cellular suppressor function in the pathogenesis of type I diabetes mellitus.

  2009cites this paper
• Polyglandular autoimmune syndromes.

  2009cites this paper
• A follow-up study of cell-mediated cytotoxicity and beta cell function in type I diabetes.

  2009cites this paper
• Diabetic ketoacidosis with cytomegalovirus-associated colitis.

  2009cites this paper
• The MHC-Based Suppression (MBS) Theory: Implications for Transplantation

  2008cites this paper
• Thyroid antibodies in thyroid diseases.

  2008cites this paper
• Autoimmune Polyglandular Syndrome Type 2

  2007cites this paper
• Medical Progress The Role of Immunotherapy in Type I Diabetes Mellitus

  2005cites this paper
• Autoimmune Endocrinopathies : Aspects of Pathogenesis and the Role of Immune Assays in Investigation and Management

  2004influential citation
• ANTIGEN-SPECIFIC SUPPRESSOR CELL FUNCTION AND AUTOIMMUNE DISEASES

  2003cites this paper
• Passive transfer of flt‐3L‐derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)‐4 and IL‐10 in the spleen of recipient mice

  2003cites this paper
• Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.

  2002cites this paper
• [Polyglandular autoimmune syndromes].

  2000cites this paper
• Manifestation einer Nebennierenrindeninsuffizienz nach Gabe von Levothyroxin bei einem Patienten mit polyglandulärem Autoimmunsyndrom Typ II (Schmidt-Syndrom)

  2000cites this paper
• GROWING AN INTEREST IN AUTOIMMUNE THYROID DISEASE: An Interview with Robert Volpé, MD, FRCP(C)

  2000cites this paper
• [Manifestation of adrenal insufficiency after administration of levothyroxine in a patient with polyglangular autoimmune syndrome type II (Schmidt-syndrome)].

  2000cites this paper
• The Polyglandular Autoimmune Syndromes

  1999cites this paper
• Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.

  1999cites this paper
• Type 1 diabetes: the facts fit a deficient inhibitory signal given by MHC Class II

  1999cites this paper
• Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice.

  1997cites this paper
• Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.

  1997cites this paper
• Type 2 Polyglandular Autoimmune Disease (Schmidt's Syndrome)

  1996cites this paper
• Effect of 5-α Dihydrotestosterone on T-cell Proliferation of the Female Nonobese Diabetic Mouse

  1996cites this paper
• Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.

  1995cites this paper
• Tissue culture supernatants from human islets of Langerhans activate the oxidative burst response of human monocytes in vitro.

  1995cites this paper
• Autoimmune endocrinopathies: aspects of pathogenesis and the role of immune assays in investigation and management.

  1994cites this paper
• Immunoregulation in Autoimmune Thyroid Disease

  1994cites this paper
• La persistance virale: un agent étiologique possible pour les maladies autoimmunes.

  1993cites this paper
• Suppressor T Lymphocyte Dysfunction Is Important in the Pathogenesis of Autoimmune Thyroid Disease: A Perspective

  1993cites this paper
• Study of induction of activation of human peripheral blood mononuclear cells with a non‐activating form of anti‐CD3 MoAb in autoimmune thyroid disease (AITD)

  1993cites this paper
• Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease

  1993cites this paper
• Re-examination of peripheral blood T cell subsets in dysthyroid orbitopathy.

  1992cites this paper
• Autoimmune thyroiditis: predisposition and pathogenesis

  1992cites this paper
• T Cells and Human Autoimmune Thyroid Disease: Emerging Data Show Lack of Need to Invoke Suppressor T Cell Problems

  1992cites this paper
• Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs.

  1991cites this paper
• Insulin dependent diabetes mellitus hypothesis of autoimmunity.

  1991cites this paper
• Cellular immunity in interstitial cystitis.

  1991cites this paper
• Soluble interleukin-2 receptor in sera of patients with Graves' disease.

  1991cites this paper
• Autoimmunity causing thyroid dysfunction.

  1991cites this paper
• Personal view INSULIN DEPENDENT DIABETES MELLITUS HYPOTHESIS OF AUTOIMMUNITY

  1991cites this paper
• Identification of cells responsible for the suppression of anti‐beta‐cell cytotoxicity in type I (insulin‐dependent) diabetes mellitus

  1991cites this paper
• Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.

  1991cites this paper
• Increased level of soluble interleukin-2 receptor in sera of patients with Graves' disease.

  1991cites this paper
• Multiple sclerosis: cell-mediated immunity to human brain gangliosides.

  1990cites this paper
• Hypothesis THE IMMUNOGENETIC BASIS OF AUTOIMMUNITY

  1990cites this paper
• The immunogenetic basis of autoimmunity.

  1990cites this paper
• Virus-induced autoimmunity.

  1990cites this paper
• The immunogenetic basis of autoimmunity.

  1990cites this paper
• Autoimmunity and the pathogenesis of glomerulonephritis

  1990cites this paper
• [Autoimmune polyglandular syndrome. Clinical experience in 21 cases].

  1990cites this paper
• The significance of T suppressor cells in the development of autoimmunity.

  1989cites this paper
• Immunological aspects of diabetes mellitus: prospects for pharmacological modification.

  1989cites this paper
• Pathogenesis of type I (insulin-dependent) diabetes: possible mechanisms of autoimmune damage.

  1989cites this paper
• HYPOTHESIS THE IMMUNOREGULATORY DISTURBANCE IN AUTOIMMUNE THYROID DISEASE

  1988cites this paper
• Autoimmune thyroid disease: immunological, pathological, and clinical aspects.

  1988cites this paper
• Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders.

  1988cites this paper
• On the pathogenesis of insulin-dependent diabetes mellitus.

  1988cites this paper
• Dysthyroid orbitopathy associated with diffuse periorbital sinusitis

  1988cites this paper
• The Respiratory Burst and Its Physiological Significance

  1988cites this paper
• HLA-DR Antigen Expression on the Thyrocytes of Graves’ Disease Patients

  1988cites this paper
• Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.

  1988cites this paper
• The immunoregulatory disturbance in autoimmune thyroid disease.

  1988cites this paper
• The Respiratory Burst and Diabetes Mellitus

  1988cites this paper
• Polyglandular autoimmune syndrome: current concepts.

  1988cites this paper
• Autoantibodies to Insulin Are Present in Sera of Patients With Autoimmune Thyroid Disease

  1988cites this paper
• Normal suppressive T cell function of Epstein-Barr virus-induced B cell activation in Graves' disease.

  1987cites this paper
• Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves' disease.

  1987cites this paper
• The role of T lymphocytes in autoimmune thyroid disease.

  1987cites this paper
• CELLULAR AND HUMORAL IMMUNITY IN PATIENTS WITH HYPERTHYROID GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID DRUG TREATMENT

  1987cites this paper
• The origin of autoantibodies.

  1987cites this paper
• Environmental factors affecting autoimmune thyroid disease.

  1987cites this paper
• [Physiopathology of autoimmune endocrine diseases: current concepts].

  1987cites this paper
• Multiple immunological abnormalities in patients with Type 1 (insulin-dependent) diabetes mellitus

  1987influential citation
• Immunologic mechanisms in intestinal diseases.

  1987cites this paper
• The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.

  1987cites this paper
• The role of immunotherapy in type I diabetes mellitus.

  1987cites this paper
• Mechanisms of autoimmunity: relevance to the pathogenesis of type I (insulin-dependent) diabetes mellitus.

  1987cites this paper
• Intrathyroidal MHC class II antigen expression and thyroid autoimmunity.

  1987cites this paper
• Immunoregulatory Abnormalities in Autoimmune Thyroid Disease

  1987cites this paper
• Studies on auto-anti-idiotypic thyroid-stimulating antibodies.

  1986cites this paper
• Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis.

  1986cites this paper
• EVIDENCE THAT ANTITHYROID DRUGS INDUCE REMISSIONS IN GRAVEs' DISEASE BY MODULATING THYROID CELLULAR ACTIVITY

  1986cites this paper
• Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.

  1986cites this paper
• Restricted heterogeneity and T cell dependence of human thyroid autoantibody immunoglobulin G subclasses.

  1986cites this paper
• Autoimmune thyroid disease.

  1986cites this paper
• Serum from patients with autoimmune diseases induces in vitro production of disease-associated antibodies by peripheral blood mononuclear cells from normal subjects.

  1986cites this paper
• T-suppressor cell defects in euthyroid nonendemic goitre.

  1986cites this paper
• Cell-mediated immune reactions against B cells and defect of suppressor cell activity in Type 1 (insulin-dependent) diabetes mellitus

  1986cites this paper
• Immunological features of insulin-dependent diabetes mellitus

  1986cites this paper
• Family studies in autoimmune thyroid disease.

  1986cites this paper
• TheTcell suppressor defect inautoimmune thyroiditis: evidence forahigh set'autoimmunostat'

  1986cites this paper
• In vitro regulation of antithyroglobulin synthesis by lymphocytes of patients with Hashimoto's disease by an antigen-specific "suppressor factor" derived from cultured normal human T-lymphocytes.

  1986cites this paper
• The T cell suppressor defect in autoimmune thyroiditis: evidence for a high set 'autoimmunostat'.

  1986cites this paper